Suppr超能文献

马来西亚半岛东北部女性乳腺癌的生存时间及预后因素

Survival Time and Prognostic Factors for Breast Cancer among Women in North-East Peninsular Malaysia.

作者信息

Nordin Noorfariza, Yaacob Najib Majdi, Abdullah Noor Hashimah, Mohd Hairon Suhaily

机构信息

Department of Community Medicine, School of Medical Sciences, Universiti Sains, Malaysia. Email:

出版信息

Asian Pac J Cancer Prev. 2018 Feb 26;19(2):497-502. doi: 10.22034/APJCP.2018.19.2.497.

Abstract

Background: Breast cancer is the most common malignant disease and the leading cause of cancer death among women globally. This study aimed to determine the median survival time and prognostic factors for breast cancer patients in a North-East State of Malaysia. Methods: This retrospective cohort study was conducted from January till April 2017 using secondary data obtained from the state’s cancer registry. All 549 cases of breast cancer diagnosed from 1st January 2007 until 31st December 2011 were selected and retrospectively followed-up until 31st December 2016. Sociodemographic and clinical information was collected to determine prognostic factors. Results: The average (SD) age at diagnosis was 50.4 (11.2) years, the majority of patients having Malay ethnicity (85.8%) and a histology of ductal carcinoma (81.5%). Median survival times for those presenting at stages III and IV were 50.8 (95% CI: 25.34, 76.19) and 6.9 (95% CI: 3.21, 10.61) months, respectively. Ethnicity (Adj. HR for Malay vs non-Malay ethnicity=2.52; 95% CI: 1.54, 4.13; p<0.001), stage at presentation (Adj. HR for Stage III vs Stage I=2.31; 95% CI: 1.57, 3.39; p<0.001 and Adj. HR for Stage IV vs Stage I=6.20; 95% CI: 4.45, 8.65; p<0.001), and history of surgical treatment (Adj. HR for patients with no surgical intervention=1.95; 95% CI: 1.52, 2.52; p<0.001) were observed to be the statistically significant prognostic factors associated with death caused by breast cancer. Conclusion: The median survival time among breast cancer patients in North-East State of Malaysia was short as compared to other studies. Primary and secondary prevention aimed at early diagnosis and surgical management of breast cancer, particularly among the Malay ethnic group, could improve treatment outcome.

摘要

背景

乳腺癌是全球女性中最常见的恶性疾病及癌症死亡的主要原因。本研究旨在确定马来西亚东北部一个州乳腺癌患者的中位生存时间及预后因素。方法:本回顾性队列研究于2017年1月至4月进行,使用从该州癌症登记处获得的二手数据。选取2007年1月1日至2011年12月31日期间诊断的所有549例乳腺癌病例,并对其进行回顾性随访直至2016年12月31日。收集社会人口统计学和临床信息以确定预后因素。结果:诊断时的平均(标准差)年龄为50.4(11.2)岁,大多数患者为马来族裔(85.8%),组织学类型为导管癌(81.5%)。III期和IV期患者的中位生存时间分别为50.8(95%置信区间:25.34,76.19)个月和6.9(95%置信区间:3.21,10.61)个月。种族(马来族与非马来族裔的调整后风险比=2.52;95%置信区间:1.54,4.13;p<0.001)、就诊时的分期(III期与I期的调整后风险比=2.31;95%置信区间:1.57,3.39;p<0.001以及IV期与I期的调整后风险比=6.20;95%置信区间:4.45,8.65;p<0.001)和手术治疗史(未进行手术干预患者的调整后风险比=1.95;95%置信区间:1.52,2.52;p<0.001)被观察到是与乳腺癌死亡相关的具有统计学意义的预后因素。结论:与其他研究相比,马来西亚东北部州乳腺癌患者的中位生存时间较短。针对乳腺癌的早期诊断和手术管理的一级和二级预防,特别是在马来族裔群体中,可以改善治疗结果。

相似文献

1
Survival Time and Prognostic Factors for Breast Cancer among Women in North-East Peninsular Malaysia.
Asian Pac J Cancer Prev. 2018 Feb 26;19(2):497-502. doi: 10.22034/APJCP.2018.19.2.497.
5
Breast cancer in Sabah, Malaysia: a two year prospective study.
Asian Pac J Cancer Prev. 2007 Oct-Dec;8(4):525-9.
7
Diagnosis delay of breast cancer and its associated factors in Malaysian women.
BMC Cancer. 2011 Apr 17;11:141. doi: 10.1186/1471-2407-11-141.
8
Survival and prognostic factors of stage I-III breast cancer.
J Med Assoc Thai. 2013 Mar;96 Suppl 3:S23-34.

引用本文的文献

2
3
Neoadjuvant chemotherapy response, disease-free survival, and overall survival of breast cancer in a single institution.
Surg Open Sci. 2023 Jul 27;15:19-25. doi: 10.1016/j.sopen.2023.07.016. eCollection 2023 Sep.
6
Development of Predictive Models for Survival among Women with Breast Cancer in Malaysia.
Int J Environ Res Public Health. 2022 Nov 20;19(22):15335. doi: 10.3390/ijerph192215335.
7
Prognostic Factors for Bladder Cancer Patients in Malaysia: A Population-Based Study.
Int J Environ Res Public Health. 2022 Mar 4;19(5):3029. doi: 10.3390/ijerph19053029.
8
A comparison of breast cancer survival across different age groups: a multicentric database study in Penang, Malaysia.
Epidemiol Health. 2021;43:e2021038. doi: 10.4178/epih.e2021038. Epub 2021 May 25.

本文引用的文献

1
Better survival in PMRT of female breast cancer patients with >5 negative lymph nodes: A population-based study.
Medicine (Baltimore). 2017 Jan;96(4):e5998. doi: 10.1097/MD.0000000000005998.
2
Impact of Treatment Type on Overall Survival in ElderlyBrazilian Women with Breast Cancer.
Asian Pac J Cancer Prev. 2016 Oct 1;17(10):4769-4774. doi: 10.22034/apjcp.2016.17.10.4769.
4
Improved survival in metastatic breast cancer 1985-2016.
Breast. 2017 Feb;31:46-50. doi: 10.1016/j.breast.2016.10.005. Epub 2016 Nov 2.
5
Prognostic factors in advanced breast cancer: Race and receptor status are significant after development of metastasis.
Pathol Res Pract. 2016 Jan;212(1):24-30. doi: 10.1016/j.prp.2015.11.003. Epub 2015 Nov 10.
6
Surgery improves survival in elderly with breast cancer. A study of 465 patients in a single institution.
Eur J Surg Oncol. 2015 May;41(5):635-40. doi: 10.1016/j.ejso.2015.01.027. Epub 2015 Feb 10.
7
Survival time and molecular subtypes of breast cancer after radiotherapy in Thailand.
Asian Pac J Cancer Prev. 2014;15(23):10505-8. doi: 10.7314/apjcp.2014.15.23.10505.
8
A review of breast cancer research in malaysia.
Med J Malaysia. 2014 Aug;69 Suppl A:8-22.
10
Incidence and mortality of female breast cancer in the Asia-Pacific region.
Cancer Biol Med. 2014 Jun;11(2):101-15. doi: 10.7497/j.issn.2095-3941.2014.02.005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验